Plasmapheresis in Immunologically Mediated Polyneuropathies

:  One of the most common uses of therapeutic plasmapheresis is for the treatment of immunologically mediated polyneuropathies. This paper discusses the use of plasmapheresis in Guillain‐Barré syndrome, chronic inflammatory demyelinating polyneuropathy, polyneuropathies associated with paraproteins,...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis 2003-04, Vol.7 (2), p.189-196
Main Authors: Kiprov, Dobri D., Hofmann, Jan C.
Format: Article
Language:English
Subjects:
Apheresis
HIV Infections - complications
Human immunodeficiency virus
Humans
Immune System Diseases - therapy
Immunologic
Peripheral Neuropathy
Plasma Exchange
Plasmapheresis
Plasmapheresis - methods
Polyneuropathies - etiology
Polyneuropathies - therapy
Polyneuropathy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary::  One of the most common uses of therapeutic plasmapheresis is for the treatment of immunologically mediated polyneuropathies. This paper discusses the use of plasmapheresis in Guillain‐Barré syndrome, chronic inflammatory demyelinating polyneuropathy, polyneuropathies associated with paraproteins, lower motor neuron syndromes, and polyneuropathies associated with HIV. As the pathogenesis of immunologically mediated polyneuropathies becomes better understood, newer therapies for these syndromes will evolve; however, therapeutic plasmapheresis is likely to continue to play a central role in the treatment of many of these diseases.
ISSN:1744-9979
1091-6660
1744-9987
DOI:10.1046/j.1526-0968.2003.00028.x